Infectious Disease & Vaccine Solutions

Offering global Infectious Disease and Vaccine CRO services in support of clinical research for emerging and re-emerging diseases.

Our extensive experience in the conduct of trials in infectious diseases caused by viruses, bacteria, fungi or parasites, including COVID-19, provides a significant advantage in proven strategic planning, regulatory guidance, and successful clinical trial execution.

Extensive Infectious Diseases and Vaccines Expertise

It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Pharm-Olam’s therapeutically aligned, specialized staff have a broad range of expertise in Infectious Disease and Vaccine clinical development and regulations from the US, EU, and beyond with 85% of PMs and 80% of CRAs currently on staff having worked, or are actively working in, infectious disease and vaccines trials.

Infectious-Disease-Experience-Wheel@2x

COVID19 (vaccines/treatment)

HIV

C. difficile

Norovirus

Pneumonia (CAP, HAP, VAP)

Hepatitis B

Hepatitis C

HPV

Influenza A, B, C

RSV

Complicated Intra-abdominal infection

Complicated skin and skin structure infections

Urinary tract infection (complicated and non-complicated)

Tuberculosis

Upper respiratory tract infection

Sepsis/septic shock

Otitis media

Prosthetic joint infection

Impetigo

Common cold

Bronchiectasis

Cellulitis

Tinea pedis

Traveler's diarrhea

Sponsor Testimonial

“Working with Pharm-Olam was an absolute pleasure. The entire team was very knowledgeable, professional and customer focused. They showed an excellent level of organization and were always on top of any issues.”

Biotech - Director ClinOps

Request a Proposal

Global Infectious Disease & Vaccine Expertise

Vaccine Development Specialization

Our Vaccines Development experts have extensive experience designing, implementing, and executing clinical trials involving live attenuated, inactivated, subunit, toxoid, mRNA, and viral vector vaccines for infectious diseases, allergies, immunotherapies, and oncology indications including; COVID-19, Hepatitis B & C, grass, birch, and dust mite allergies, cervical cancer and melanoma.

Monitoring Strategies for Vaccine Trials

Data-driven, risk-based monitoring solutions, including centralized monitoring, designed specifically to take into account large data volume upon enrolment of vaccine trials, whilst ensuring data integrity in remote settings.

Patient Recruitment - Global, Regional, Seasonal

Natural selection of pathogens, diversity of trial participants, and timing are all important site selection criteria for infectious disease clinical trials. Our global reach, including industry-leading Central & Eastern Europe specialization, provides access to patient populations, site networks, and academic institutions, focused on meeting and exceeding your enrolment goals.

Critical Care Setting Experts

Pharm-Olam's teams have deep expertise in supporting studies in an ICU/critical care setting and navigating the common challenges encountered in this complex environment. That knowledge enables us to provide proactive and insightful CRO services based on proven strategies for indications from Pneumonia to COVID-19 and everywhere in between.

Federal Research CRO Solutions

We have supported federally-funded vaccine and infectious disease clinical research programs for more than 20 years. Our proven track record has allowed us to collaborate with multiple government agencies including NIH, DOD, BARDA, and CDC.

Regulatory Strategies & Submissions Team

Whether your new product is a drug, vaccine, biologic, GMO, cell and gene therapy, device, or a combination product, we understand the nuances of regulatory requirements and have the resources and proven expertise to address your specific needs.

Infectious Disease & Vaccine Clinical Research By The Numbers

In the past several years our teams have supported over 75 infectious diseases and vaccine trials across a variety of therapeutic areas and indications, including 14 product approvals.

Infectious Disease and
Vaccine Trials

Product Approvals

Pharm-Olam Supporting COVID-19 Research

Pharm-Olam stands with the global community in the fight against COVID-19. No other disease in recent history has captured the world like Coronavirus. As a Vaccine and Infectious Disease CRO, we are poised to help pharmaceutical and biotech’s by rapidly deploying their clinical trials in the search for vaccines and therapies to fight infectious disease. Together, we can create a healthier world.

Our Participation in OWS

We have several ongoing COVID-19 studies and are proud to have been selected by the US Department of Defense as a prime CRO contractor in support of Operation Warp Speed and continue these efforts through ongoing activities in support of its successor, the Countermeasures Acceleration Group (CAG).

Learn about OWS

COVID-19 CRO Services

We understand that drug development partners with medical countermeasures (MCM) expertise are crucial in bringing vaccines and treatments to the front lines of the COVID-19 battle. As an MCM-capable CRO, Pharm-Olam is ready to go the distance.

Learn About Our COVID-19 Services

Seeking Government Funding for Your Project?

We can help! Pharm-Olam currently holds memberships in the Medical CBRN Defense Consortium (MCDC). We also work with the DoD's Other Transaction Authority (OTA) and under Other Transactions (OTs).

Request A Posposal

Infectious Disease & Vaccine Resources

Article: Respiratory Viral Infections: Progress and Innovation

The impact respiratory viral infections have on the health and well-being of the world’s populations has been brought to the forefront with the ongoing COVID-19 pandemic. In this article, Dr. Kelly McKee discusses recent progress and innovations within RSV research.

Learn More

Fact Sheet: Infectious Disease & Vaccines

Pharm-Olam has supported over 75 infectious disease and vaccine clinical trials including 14 product approvals. Download the fact sheet to learn more about our global reach and expertise in Infectious Disease and Vaccine Clinical Research.

Download Now

Case Study: Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Pharm-Olam provided a complete enrollment solution for the management and data submission of this Acute Bacterial Skin and Skin Structure Infection Study.

Read Case Study